Suppr超能文献

急性淋巴细胞白血病和慢性淋巴细胞白血病患者骨髓细胞中生存素的差异表达。

Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.

作者信息

Nakagawa Yasunori, Yamaguchi Shuichi, Hasegawa Maki, Nemoto Tetsuo, Inoue Miori, Suzuki Kenshi, Hirokawa Katsuiku, Kitagawa Masanobu

机构信息

Department of Pathology and Immunology, Aging and Developmental Sciences, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.

出版信息

Leuk Res. 2004 May;28(5):487-94. doi: 10.1016/j.leukres.2003.10.013.

Abstract

Survivin, a member of the inhibitor of apoptosis protein (IAP) gene family, has been detected widely in fetal tissue and in a variety of human malignancies. In the current study, we investigated the expression of IAP family proteins in bone marrow samples from acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL) and control cases by quantitative real-time RT-PCR method and an immunohistochemical approach. Overexpression of survivin and cIAP2 mRNA was significant in CLL bone marrow cells (P < 0.05, respectively) compared with control samples. By immunohistochemistry, survivin was detected in a few scattered myeloid cells in all cases of control bone marrow. Concerning the ALL bone marrow, more than half the cases demonstrated positive expression of survivin (8 out of 13), while the majority of CLL cases (20 out of 21) exhibited intense expression of survivin. The differential subcellular localization of survivin was distinct between ALL and CLL cases. ALL cells essentially revealed nuclear localization of survivin as well as cytoplasmic signals in some cases, while CLL cells from the majority of cases predominantly showed cytoplasmic expression. Next, RT-PCR was performed for the expression of survivin and its splicing variant, survivin-2B and survivin-deltaEx3 in ALL and CLL cells, as the distribution of these variants would be regulated by nuclear/cytoplasmic transport system. In both ALL and CLL bone marrow samples, the expression of wild-type survivin was more predominant than that of survivin-2B or survivin-deltaEx3, although the expression of survivin-deltaEx3 was prominent in samples from survivin-expressing ALL cases. Thus, the splicing of survivin mRNA may be differently regulated in ALL and CLL cells, causing distinct manners of nuclear/cytoplasmic transport of survivin protein. In conclusion, our observations indicate a differential regulatory mechanism for the expression of IAP family proteins in ALL and CLL cells, although the functions of IAP families and the mechanisms of nuclear/cytoplasmic transport of survivin should be clarified in future studies.

摘要

存活素是凋亡抑制蛋白(IAP)基因家族的成员之一,已在胎儿组织和多种人类恶性肿瘤中广泛检测到。在本研究中,我们通过定量实时逆转录聚合酶链反应(RT-PCR)方法和免疫组织化学方法,研究了急性淋巴细胞白血病(ALL)、慢性淋巴细胞白血病(CLL)患者及对照病例骨髓样本中IAP家族蛋白的表达情况。与对照样本相比,CLL骨髓细胞中存活素和细胞凋亡抑制蛋白2(cIAP2)mRNA的表达显著上调(P均<0.05)。免疫组织化学检测显示,对照骨髓所有病例中仅少数散在的髓样细胞检测到存活素。在ALL骨髓中,超过半数病例(13例中的8例)存活素呈阳性表达,而大多数CLL病例(21例中的20例)存活素呈强表达。ALL和CLL病例中存活素的亚细胞定位存在差异。ALL细胞中存活素主要定位于细胞核,部分病例也有胞质信号,而大多数CLL细胞主要表现为胞质表达。接下来,对ALL和CLL细胞中存活素及其剪接变体survivin-2B和survivin-deltaEx3进行RT-PCR检测,因为这些变体的分布受核/胞质转运系统调控。在ALL和CLL骨髓样本中,野生型存活素的表达均比survivin-2B或survivin-deltaEx3更占优势,不过survivin-deltaEx3在存活素表达阳性的ALL病例样本中表达突出。因此,ALL和CLL细胞中存活素mRNA的剪接调控可能不同,导致存活素蛋白核/胞质转运方式各异。总之,我们的观察结果表明ALL和CLL细胞中IAP家族蛋白的表达存在差异调控机制,不过IAP家族的功能以及存活素核/胞质转运的机制仍有待未来研究阐明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验